HES1 and neoplasm: miR-199b also targets Notch signaling in CSCs by targeting HES1, with similar tumor suppressive results in vivo.85 The negative correlation between miR-199b and metastasis and prognosis suggests that miR-199b-based therapy could be used to improve survival in high-risk patients.